COX-2s Left Out Of Drug Classes, Will Go Up Against Other NSAIDs

COX-2 inhibitors are among the drugs where Medicare coverage would be "recommended," but not required, under the U.S. Pharmacopeia's model formulary

More from Archive

More from Pink Sheet